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Objective: Advances in melanocyte culture techniques have not yet led to reliable clinical
methods for treating hypopigmentation disorders. We hypothesized that melanocytes
harvested from plucked hair follicles may provide a renewable source of melanocytes
for the treatment of hypopigmentation. Methods: Hairs with attached cells from the
follicles were plucked from Yucatan pigs and implanted in a collagen-glycosaminoglycan
matrix for either immediate or delayed implantation into full-thickness excisional porcine
wounds. Wounds were allowed to heal and were biopsied at 2 and 4 weeks, respectively.
Results: Fully healed wounds with transplanted hair follicles showed central areas of dark
pigmentation corresponding to the location of implanted hair follicles. Corresponding
collagen-glycosaminoglycan matrix wounds showed no central areas of pigmentation.
Conclusions: Hair follicle–derived melanocytes may potentially serve as a renewable
source of pigment-producing cells for treating hypopigmentation disorders.
Skin color is due to a complex interaction between ambient light and cutaneous
biomolecules. Arterialized blood flow brings hemoglobin near the skin surface and gives a
red hue to the skin. Melanocytes produce a dark polymer known as melanin, which gives
skin its dark color. Derived from neural crest cells, melanocytes have physical connections
to keratinocytes through which melanin granules are deposited. Skin pigmentation varies
greatly depending on the location on the body or the race of an individual.
Pigmentation disorders are common and can result in either an over- or underexpression
of melanin. Hyperpigmentation disorders are frequently seen after trauma and burns and
can result in a skin color dramatically darker than the surrounding uninjured skin. Loss
of melanocytes or decreases in melanin production leads to pigmentation disorders. These
are most commonly seen in aging hair because it becomes gray or white over time. In
addition, burns, laser therapy, and autoimmune disorders (eg, vitiligo) can also result in
skin hypopigmentation.
Until the 1980s, it was not possible to grow melanocytes in vitro. This view changed
when Eisinger and Marko1 demonstrated that melanocytes could be cultured and serially
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passaged using culture medium containing 12-O-tetradecanoyl-phorbol-13-acetate (TPA).
However, phorbol esters, including TPA, were also demonstrated to be toxic to keratinocytes
and limited their usefulness for in vitro melanocyte studies and clinical applications. Al-
though there have been no reports of melanocyte mutations, malignant transformations of
melanocytes grown using phorbol esters continue to be of concern.
Lerner et al2 demonstrated that the use of cultured and noncultured epithelial
melanocytes could be effective in the treatment of patients affected by piebaldism. Falabella
et al3 further demonstrated that culture medium could be developed to culture epidermal
melanocytes in vitro without the use of potentially oncogenic reagents such as phorbol
esters. These methods allow epidermal melanocytes to be incorporated into artificial skin
constructs, to repopulate skin melanocytes using a cell spray apparatus, or permit their
autotransplantation from shaved skin biopsies.4−8 These experiments resulted in the devel-
opment of currently practiced techniques for treating pigmentation disorders such as vitiligo
and leukoderma.9 These treatment modalities include epithelial sheet grafting, mini graft-
ing, epidermal grafting with suction blisters, and transplantation of in vitro cultured skin
melanocytes via skin blister injections. Despite these ongoing efforts, no widely accepted
method is currently available for treating clinical hypopigmentation.
Current methods use epidermal melanocytes requiring at least a small skin biopsy.
This limits immediate autologous melanocyte transplantation and necessitates in vitro
melanocyte culture before transplantation. Rather than depending on the limited supply
of epidermal melanocytes from skin biopsies, we propose to use melanocytes found in the
upper outer hair follicle root sheath. It has been known that these melanocytes are capable of
migrating from these reservoirs to pigment their respective hair follicles. Nishimura et al10
further demonstrated in a mouse model that melanocyte stem cells can be found in the lower
permanent portion of the hair follicle. These stem cells were shown to be able to migrate
to “niches” lacking melanocytes and repopulate them. They further suggest that these stem
cells could potentially be the source for both hair follicle and epidermal melanocytes. In this
study, we use plucked hair follicle melanocytes to show repigmentation in a porcine model.
MATERIALS AND METHODS
Porcine model
All animals were treated in an AAALAC-approved facility under an approved animal pro-
tocol. Three 2-month-old Yucatan mini pigs (Charles River, Wilmington, MA) were housed
and treated in the animal care facility at Brigham and Women’s Hospital (Boston, MA) for
at least 3 days before the start of each experiment. After acclimation, the pigs were sedated
(telazol 5 mg/kg IM and xylazine 2 mg/kg IM) and transported into our animal operating
room. General anesthesia was administered via snout mask using halothane (1.5%–3.0%),
oxygen (4–6 L/min), and nitrous oxide (2–3 L/min) and monitored using continuous pulse
oximetry. The dorsum and scalp of the pig was scrubbed and painted 3 times using a betadine
solution. Hair follicles were then plucked from these areas and immediately transferred into
an enriched Gibco keratinocyte serum-free media (S-FM; Invitrogen, Carlsbad, CA).
Sixteen 3.0×3.0-cm full-thickness skin wounds were incised on the paraspinous
region of the dorsum. Hemostasis was obtained with direct pressure and electrocautery.
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Collagen-glycosaminoglycan (GAG) matrices, either with or without hair follicles, were
sutured in place and stabilized using a semiocclusive polyurethane dressing (Tegaderm, St.
Paul, MN), gauze, and a protective cotton vest.
Harvesting hair follicles
Anagen phase hair follicles were plucked from the scalp and back of a Yucatan pig. All
plucked hair follicles were immediately transferred into an enriched Gibco keratinocyte
S-FM and subsequently examined under a microscope to ensure that hair root bulbs and
sheath were intact. We also removed excess hair root debris from around each bulb. Hair
follicles were then implanted into collagen-GAG matrices after being stained with a PKH26
fluorescent dye for cell tracking, and either immediately placed into newly created full-
thickness skin wounds or grown in cell culture media for 2 weeks before implantation.
After the matrices containing 3 hair follicles were applied to the dorsal wounds of each pig,
they were covered with Tegaderm and followed daily until complete wound healing (Fig 1).
Figure 1. Diagram depicting the harvesting and
transplantation of plucked hair follicles.
Collagen-CAG matrices
Porous matrices were prepared using a procedure initially described by Yannas et al.11
A collagen dispersion was prepared using 0.5% bovine hide collagen (Sigma Chemical,
St. Louis, MO) in 0.05 M acetic acid (pH 3.2) with chondroitin 6-sulfate (sodium salt,
Type C, Sigma Chemical, St. Louis, MO) in a custom-built blender with an internal cooling
apparatus. This was poured into a 3-mm thick stainless steel pan and transferred to a freeze
dryer with a shelf temperature of −40◦C (Virtis Unitop 800, Gardiner, NY) for 20 hours.
After lyophilization, matrices were cross-linked using a dehydrothermal treatment at 105◦C
for 24 hours, followed by UV irradiation at 254 nm at 4510 µW/cm2 for 45 minutes.
Matrices were then cut into 3.0×3.0-cm squares under sterile conditions.
Cell culture
We used an enriched Gibco keratinocyte S-FM for storing harvested hair follicles, hy-
drating collagen-GAG matrices before follicle placement and coverage of wounds, and
culturing follicular melanocytes in vitro. This media consists of using keratinocyte S-FM
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supplemented with pituitary extract (Invitrogen, Carlsbad, CA), epidermal growth factor
(EGF) (R&D Systems, Minneapolis, MD), pen-strep-Glutamine (PSQ) (Shimazu, Kyoto,
Japan), hFGF, and TPA (Sigma, St. Louis, MO).
PKH26 fluorescent red stain
Harvested hair follicles were rinsed using a phosphate buffered saline solution and then
stained using PKH26 fluorescent cell linker (Sigma, St. Louis, MO) for cell tracking.
One group (n = 8) was immediately placed on to collagen-GAG matrices for immediate
transplantation, whereas a second group (n = 8) was grown in enriched keratinocyte S-FM
for 2 weeks before transplantation.
Melanocyte transplantation
Follicular melanocytes using 3.0×3.0-cm collagen-GAG matrices as a delivery agent were
transplanted into newly created 3-cm2 full-thickness skin wounds on day 0 and day 14.
Follicular melanocytes that were transplanted on day 0 were stained after being harvested
and immediately reimplanted into dorsal wounds (n = 8). Melanocytes transplanted on
day 14 were grown in vitro for 2 weeks before transplantation (n = 8). All wounds were
covered with a semiocclusive polyurethane dressing and followed daily until complete
wound healing.
Wound harvesting and histology
Wounds were harvested on day 14 and day 28 under general anesthesia with a 1-cm margin
of normal tissue. After biopsies were taken on day 14, the resulting wounds were covered
with isotonic sodium chloride solution–soaked collagen-GAG matrices and using the same
polyurethane dressing. After biopsies were taken on day 28, each animal was euthanized.
One set of biopsy specimens was stored in 10% formalin, transferred to cassettes, embed-
ded, sectioned, and stained with hematoxylin and eosin. Two observers, both blinded to
the specimen groups, independently counted the number of melanocytes present in each
wound. The second set of biopsy specimens was frozen immediately using liquid nitrogen
and stained with a DAPI solution in phosphate buffered saline for visualization under a
fluorescent microscope (Axioplan 2 Imaging, Zeiss, TMS, Nikon). Images of histological
slides were taken using an inverted microscope at 200× magnification. Cell counting was
performed using the same microscope under 400× magnification.
Results
Hair follicle melanocytes begin to proliferate in the early Anagen II stage and continue
through the Anagen III stage of the hair growth cycle. After harvesting, melanocytes were
either grown in vitro using enriched keratinocyte S-FM culture for 2 weeks or transplanted
immediately.
Among the cultured melanocytes, a pigmented area was identified around the
implanted hair follicle in the matrix before transplantation (Fig 1). This area corresponds
to an area of potential melanocyte migration from the hair follicle bulb. We could see
the pigmented area around the base of cultured hair follicles on both day 7 and day 14.
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After the transplantation, the dark-brown-colored area (arrow) is still visible around the
transplanted hair follicle (Fig 2).
Figure 2. Hair follicles grown in vitro. Hair folli-
cle stalks demonstrate darker pigmentation at after
2 weeks of incubation in enriched keratinocyte serum-
free media.
When hair follicles were transplanted immediately after harvest and allowed to heal,
we were also able to identify the pigmented area 2 weeks posttransplantation. This pig-
mented area is similar to that seen among cultured melanocytes. We could see a dark-brown
area around the transplanted hair follicles, whereas no pigmentation was observed in the
nontransplanted wound. Over time, as the surgical wounds healed, this dark-brown color
became more pronounced (Fig 3).
Figure 3. Healing wounds 2 weeks postoperatively.
Melanocyte-transplanted wounds (transplantation site)
(right) demonstrate central areas of pigmentation, whereas
nontransplanted wounds contain no pigmentation (control
site) (left).
After complete healing (4 weeks posttransplantation), central areas of pigmentation
observed in hair follicle transplanted wounds appeared even darker and thicker than their
counterparts at 2 weeks posttransplantation (Fig 4). Despite marked wound contraction, a
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rim of nonpigmented tissue visibly demarcated the central area of hair follicle melanocyte
pigmentation from the rim of epidermal melanocyte pigmentation surrounding each wound.
Figure 4. Healed wounds 4 weeks postoperatively. Trans-
planted wounds (transplantation site) (right) exhibit darker
central areas of pigmentation than nontransplanted wounds
(control site) (left).
Histological sections of the wound show that a large number of melanocytes per high-
power field can be seen in transplanted wounds (Fig 5). The study wound contained 6.0 ±
1.4 pigmented melanocytes per high-power field, whereas control wounds had only 0.2 ±
0.4 pigmented melanocytes.
Figure 5. Histological sections of control wound (non-
transplantation wound: 0.2 ± 0.4 pigmented melanocytes)
(left) and melanocyte-transplanted wound (transplant wound:
6.0 ± 1.4 pigmented melanocytes) (right) harvested at
4 weeks postoperatively.
To distinguish follicular melanocytes from their epidermal counterparts, plucked hairs
were stained with PKH26 fluorescent dye for cell tracking before transplantation (Fig 6).
We detected PKH26-positive cells containing melanin pigments in the transplanted areas,
indicating that melanocytes in the pigmented area are derived from the follicle implant
(Fig 7).
DISCUSSION
We were able to demonstrate that melanocytes from plucked hair follicles were viable and
proliferated both in vitro and in vivo. Unlike epidermal skin melanocytes, plucked hair
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follicular melanocytes are much easier to harvest, are less invasive, and lack donor site
morbidity in terms of scarring and color changes.
Figure 6. PKH26-stained fol-
licular melanocytes in the hair
bulb as seen under a fluores-
cent microscope using a Texas
red view.
Figure 7. DIC views revealing dark-colored melanocytes
(left) and overlapping Texas red and DAPI views (right) of
histological specimens from transplanted wounds.
In the treatment of severe burns, cultured epidermal autografts have frequently shown
irregular areas of hypopigmentation. Melanocytes in cultured epithelial grafts are usu-
ally depleted with serial subcultivation and cryopreservation.12 Transferred using either an
artificial collagen matrix–containing hair follicle melanocytes or the plucked hair bulbs
themselves as a micrograft into normal skin would provide a simple, effective, and low-
morbidity alternative to current practices. This would eliminate the need for invasive tissue
sampling, laborious melanocyte extraction procedures, and the use of potentially toxic
phorbol-based melanocyte culture media. Hair follicle–derived melanocyte stem cells are
flexible, adaptable, and ready-to-use immediately.
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We showed that follicular melanocytes, in addition to their ability to migrate up a hair
follicle to give it a characteristic color, are capable of migrating out into the surrounding
melanocyte-deficient skin.13,14 Transplanted follicular melanocytes, labeled using PKH26
fluorescent cell linker dye, can be found in the healed wound. Healed wounds, which were
treated with collagen-GAG matrices alone, did not show central areas of pigmentation and
no melanocytes were observed on histology. This indicates that the observed melanocytes
are of follicular rather than epidermal origin. This result is consistent with the findings of
Medalie et al,15 where transplanted epidermal melanocytes repopulated portions of acellular
dermal substitutes but stopped at the edges of the graft.
Since melanoblasts on the outer root sheath of the follicle include a stem cell population,
we have shown that it is feasible to harness this renewable source of melanocytes for clinical
and research purposes. More adaptable than differentiated melanocytes, these stem cells
are a dependable source of melanocytes for transplantation, studying their biology, and
advancing our ability to manipulate their melanin expression.
The renewable and autologous nature of this technique makes melanocyte stem cells
more conducive to both culturing and pigment manipulation. It could translate clinically
into the development of better treatments for all iatrogenic, acquired, or hereditary hair and
skin pigmentation disorders. Failed melanocyte transplants resulting in pigmentation irreg-
ularities could be salvaged through follicular melanocyte transplants. Having been shown to
affect keratinocyte differentiation and proliferation, melanocytes could potentially improve
both wound healing and pigmentation.16 Boyce et al17 further showed that cultured skin
substitutes, which contained melanocytes, improved both wound contracture and pigmen-
tation. In melanocyte-deficient skin, such as that of a healed burn wound or hypopigmented
laser resurfaced skin, melanoblasts in hair follicles could potentially reconstitute the entire
melanocyte population.
Although we cannot conclusively prove that the melanocytes grow out from the hair
follicle, the wound photographs and staining results are consistent with this hypothesis. In
addition, significant contraction observed in these cutaneous wounds is also a limitation of
this study. Navsaria et al18 have used micrografts to restore epithelium to collagen-GAG
matrices in humans with success, but no mention was made about the issue of pigmentation.
More detailed studies will be required to determine the optimal transplantation character-
istics of melanocytes attached to hair follicles.
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